ReviewBiomedicines2022

Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists.

Fernando Torres Andón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.